Pregabalin Completed Phase 4 Trials for Cryptogenic Sensory Polyneuropathy Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02260388Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations